Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review


     Quick Explanation



    This 2018 JBC study (Hanne et al.) provides bulk SPR, single-molecule TIRF/PIFE, and Tonks-gas modeling evidence that ATP-bound MSH sliding clamps reduce the association rate (k_on) of LacI binding to LacO, with a measured 9.6-fold on-rate reduction with two clamps, generalizing a roadblock-shielding mechanism to other sliding clamps like PCNA.


     Long Explanation



    Core Finding and Evidence

    Hanne et al. (J. Biol. Chem. 293:14285–14294, 2018) tested whether ATP-bound MutS homolog (MSH) sliding clamps β€” which diffuse freely along mismatched DNA for up to ~10 min β€” can shield DNA from other binding proteins (). Three orthogonal approaches converge: (1) SPR showed LacI k_on decreased with increasing MSH concentration in ATP; (2) smTIRF with photobleaching-step counting and FRET demonstrated fewer LacI-binding events as clamp number rose; (3) smPIFE directly quantified k_on_LacI = 119 Β± 22 pM K_D in the no-clamp baseline, matching historical values.

    The modeled Tonks gas (hard-core particles in 1D, footprint Οƒ β‰ˆ 26 bp) agreed well with experiment for two clamps (predicted vs observed k_on ratio 9.6 Β± 2.0 S.D.) but systematically underestimated the effect of one clamp (observed 2.6 Β± 0.9 vs lower model prediction), attributed to elasticity, hydration, and DNA stiffness deviations from ideal rods.

    Biological Interpretation

    The authors interpret the effect as k_on-specific shielding: only free proteins (or just-dissociated ones) are excluded, with little effect on k_off. This mechanistically explains prior observations that MSH clamps disassemble nucleosomes and suggests MSH+MLH/PMS double sliding clamps synergistically clear roadblocks between mismatch and excision site, potentially generalizing to PCNA and the 9-1-1 complex (). Falsification would require showing LacI kinetics unaffected by clamps under varied conditions; within this system the effect is robust.

    Critical Limitations and Blind Spots

    • In vitro reductionism: Short 95–98 bp DNAs with both ends blocked; roadblock counts and clamp confinement do not reflect kilobase-scale chromosomal DNA, where clamp density from a single mismatch is far lower and shielding magnitude correspondingly smaller.
    • Single roadblock protein: Only LacI (a very tight, specific binder, K_D ~119 pM) was tested; generality to physiological nucleosome-roadblock contexts is inferred, not measured. The nucleosome-disassembly link is drawn from prior work ().
    • Model gap at N=1: The observed one-clamp effect exceeded theory, and the mechanistic account (steric occlusion vs transient long-range accessibility reduction) is not fully resolved; alternative explanations such as ATP-bound MutS nonspecific DNA-binding modes () are not explicitly excluded.
    • Counterpoint context: Earlier work showed MutS also binds homoduplex DNA in a nucleotide-dependent manner (), so clamp loading on LacO-containing mismatched DNA itself could partially confound LacI association measurements; the mismatch position (15 bp from surface) and LacO position (12 bp from distal end) minimize but do not eliminate this concern.

    Knowledge Flow and Context

    The paper builds on the 2016 Nature cascade study showing MutS loads MutL sliding clamps (). Confidence in the central in vitro conclusion is high; confidence in in vivo relevance is moderate and untested here.



    Feedback:    

    Updated: October 12, 2026

     BGPT Paper Review



    Study Novelty

    70%

    Directly demonstrates, with a quantitative physical model, that freely diffusing MSH clamps alter association kinetics of unrelated DNA-binding proteins β€” a novel extension of the sliding-clamp paradigm, though the concept builds on the authors' prior nucleosome-disassembly and MutL-cascade work.



    Scientific Quality

    80%

    Rigorous multi-technique design with proper controls (no-ATP control, labeling-efficiency corrections, multiple orthologs). Main weakness: model-experiment mismatch at N=1 is acknowledged but not fully resolved, and only LacI was tested as a roadblock.



    Study Generality

    60%

    The Tonks-gas shielding principle is broadly applicable to any sliding clamp, but experiments are confined to short in vitro substrates and one roadblock protein; generalization to chromatin is inferential.



    Study Usefulness

    70%

    Provides a quantitative framework for how repair clamps could clear roadblocks during MMR, informing models of chromatin dynamics and protein traffic on DNA.



    Study Reproducibility

    70%

    Detailed methods, defined constructs, and clear statistical treatment; single-molecule setups are specialized but the supporting information enables replication.



    Explanatory Depth

    70%

    Mechanistic quantitative model (1D Tonks gas) links diffusion physics to kinetics; however the one-clamp discrepancy and molecular basis of shielding beyond steric exclusion remain open.


    🎁 Authors: Collect 230 Free Science Tokens (β‰ˆ $23.0 USD)

    Claim My Author Tokens

    Use for 57 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $23.0 USD)

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Active ATP-hydrolysis-driven roadblock removal: rejected because MSH clamps move purely by 1D thermal diffusion with no motor activity, yet still reduce association β€” passive shielding suffices.


    Saturating occlusion only: rejected by the single-molecule data showing subsaturating clamp numbers already reduce LacI binding frequency in a distance-dependent, model-consistent manner.

     Science Art


    Paper Review: MutS homolog sliding clamps shield the DNA from binding proteins Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT